Contents:

Wobenzym N

Wobenzym Letter

Wobenzym Enzymes

ENZYMES LOSSES ARE DEADLY

People are eating cooked foods which totally destroy all life giving enzymes. This basically removes the gasoline out of their car and their body is struggling to survive. Enzymes are needed for almost every function within the body and are mainly needed to digest foods. When we eat cooked food there are no enzymes within the foods and your immune system drastically has lower it's performance and moves it's enzymes into the digestive system.

SUPPORT HEALTHY BLOOD FLOW 
Enzymes help to break down the CICs and other dad (necrotic matter) that accumulate in the blood vessels. The body also used enzymes to regulate the amount fibrin in the blood, breaking down excess fibrin when the blood becomes too thick. With age, many people do not have enough of these enzymes. Wobenzym supports the body's natural blood-thinning process. 

http://freedompressonline.com/top_articles/wobenzym_heart.htm

Even now in his mid-eighties when he maintains great health and an active lifestyle, Dr. Heinrich Wrba remembers back to another time.

He was forty. It was after the war. One of his children -- a daughter, Michaela Siedon -- was strickened with leukemia. For two years she fought the disease, but nothing could help, and the treatments themselves were painful and debilitating to the child.

When we met for this interview he stated bluntly, "Chemotherapy killed her."

This from one of Europe's leading oncologists.

To lose a child . . .

Today with some 200 publications in prestigious medical journals, Dr. Wrba has quietly and permanently changed the way cancer is treated throughout Europe.  He has educated a generation of European oncologists on the value of systemic oral enzymes in the treatment of cancer. It hasn't been easy.  And it hasn't always been smooth sailing.  As in America, overcoming widespread negative mythologies has been one of the greatest roadblocks. But amazing things are happening on both continents-suddenly the concept that protease therapy is an important aspect of cancer treatment is catching on in a major way.

In America, the National Cancer Institute is funding a large-scale study on the value of oral enzymes in cancer treatment (see our report in volume 4.3: 10-11, 18), and the Food and Drug Administration has awarded investigational new drug status to a systemic oral enzyme formula.  Major advances in cancer therapeutics with enzyme preparations have been made in Europe as well.

Evolution of a Mainstream Doctor

It was some years after the death of his daughter when Dr. Wrba was head of the federally sanctioned Cancer Research Institute in Vienna that he met Dr. Karl Ransberger, a molecular biologist with a doctorate from Fordham University and one of the co-developers with Dr. Max Wolf of modern systemic oral enzyme therapy.

"Dr. Ransberger told me about systemic oral enzyme therapy, but, naturally, being from the academic world, I responded with the 'school opinion' that enzymes were large macromolecules that could not be absorbed from the gut. We had all learned that, once ingested, proteins are degraded into amino acids. That was my first objection-and that that was the end of the story as far as I was concerned."

Still, Dr. Ransberger persisted. He insisted Dr. Wrba take a package of the systemic oral enzyme preparation. "It was not long after that I was in a hunting party and having lunch. A servant woman, knowing I was a doctor, came up to me, hobbling, using a cane. She told me how she suffered terribly from arthritis and could hardly walk or perform her duties. I didn't know what to do for her. Out of desperation, I gave her the systemic oral enzymes. . . . A few weeks later when I returned, she was doing much better. I was impressed."

That was when Dr. Wrba contacted Drs. Ransberger and Wolf to learn more about their research into systemic oral enzyme therapy. He quickly came to realize two important facts about oral systemic enzyme therapy:

• When designed properly, oral enzymes are actually absorbed into the bloodstream where they are then able to act systemically. This process is called resorption.

• Systemic oral enzymes are effective in so many different conditions and types of disease states this leads to disbelief among medical professionals and lay persons alike that they can be of help. This was especially true in the use of enzymes and cancer. "Progress," says Dr. Wrba, "came much more quickly in all other fields such as vascular disease, rheumatology and hematology-but not for cancer therapeutics. The thinking among oncologists was and has been for so long that a 'drug' or, in this case, a natural medicine, without side effects cannot have beneficial effects. It is the age-old concept that a substance must have some poisonous qualities to be of benefit. It took such a long time for a breakthrough."

From Skeptic to True Believer

In 1965, Dr. Wrba was invited to become Chair of Oncology at the University of Vienna. Throughout his professional work, he has carried the message of oral systemic enzyme therapy to his colleagues.

What Dr. Wrba has seen in treating more than one-thousand patients and overseeing countless other cases has convinced him of the utility of systemic oral enzyme therapy in cancer therapeutics.

In Germany, systemic oral enzymes are not officially accepted for cancer therapeutics, says Dr. Wrba, yet, in practice, "almost every patient gets them."

How Systemic Oral Enzymes Help

Dr. Wrba explained how systemic oral enzymes help in the prevention of cancer and in cancer therapeutics. Cancerous or diseased cells are a fact of life, but most of these cells are quickly destroyed by the body's contingent of white blood cells which form the firewall of the immune system. Other cancerous cells wander aimlessly about via the bloodstream but are so few in number and unable to attach to any tissues that they ultimately die off.

But under detrimental influences such as environmental pollution, tobacco smoke, sunburn, radiation, and environmentally weakened or age-related lapses in immunity, the balance between friend and foe is disrupted. The body is no longer capable of suppressing the cancer cells. When a significant number of cells escape destruction, their capabilities change. Some are capable of adhering to cell walls and begin their "dirty tricks" campaign. Almost seemingly capable of sensing that the body's immune defenders might recognize them, the cancer cells hide themselves under a thick coat of adhesive fibrin, a coat that is some fifteen times more thick than the fibrin over normal cells. The thickened coat hides away their suspicious markings, including their antigens, from the body's immune defenders. The cancer cells with their sticky coating can adhere to tissues where they congregate and multiply. To throw the body's immune cells further off track, the cancerous cells may slough off their antigens. The immune cells immediately attack these harmless proteins but leave the cancerous cells unharmed. It is a type of warfare that could make a military general envious.

The cancer cells grow because of the absence or inadequate presence of enzymes that are capable of stripping the fibrin away from the individual cancer cells. Adequate enzyme activity can lay bare their antigens and so pave the way for their destruction by the body's immune cells. The more cancer cells the body produces, the more enzymes that are required.

At the Austrian Cancer Research Institute at the University of Vienna, Dr. Wrba and his researchers have long been studying the role that systemic oral enzymes play in disrupting cancerous processes. Working with Dr. Lucia Desser, the team discovered that treating cells with enzyme mixtures caused substantial secretions of a chemical called tumor necrosis factor. Tumor necrosis factor or TNF is secreted by immune cells and capable of attacking cancer cells and those cells infected with viruses. It is vital to our body's cancer defenses.

In general, enzymes are used as complementary therapy in combination with other modes of treatment. Clinical data support their efficacious use in brain tumors; epithelial tumors in the region of the head and neck; lung cancer; malignant melanoma; multiple myeloma; leukemia; T cell lymphomas; stomach and colon cancer; cancerous diseases of the abdomen; pancreatic cancer; and tumors of the cervix, breast and uterus. The benefits extend to life prolongation, quality of life, and improvement in cancer markers.

Dr. Wrba notes that Paul Ehrlich (1854-1915), a famous German physician and scientist, had already established a theory at the beginning of the century that the development of cancer is dependent on the results of the "fight" between the tumor cells and the immunological system. "The strength of the immunological system and the particular characteristics of the tumor cells are responsible for the outcome of this conflict," notes Dr. Wrba. 

"These characteristics include the malignancy of the tumor or its tendency to metastasize and to penetrate into other tissues, as well as its capability of disguising itself from the immune cells. The recognition of tumor cells by the immunological system is a very difficult procedure. It should not be forgotten that tumor cells differ only insignificantly from that of the healthy cells-a cause for problems with the defensive system. In spite of these difficulties, and according to the knowledge presently available, the health of the immunological system is nonetheless able to recognize and to destroy the great majority of tumor cells."

"As a logical consequence, there are two modes of therapy for the immunological treatment of cancer," continues the doctor. "Attempts are made both to increase the recognizability of the tumor cells for the immunological system (that is, their immunogenicity) as well as to strengthen and stimulate the various parts of the immunological system. Proteolytic enzymes are able to play a role in both aspects of this therapeutic strategy. They increase immunogenicity of the tumor cells and, at the same time, support the immunological system of patients at various levels."

Clinical Observations

"Using 20 to 30 tablets twice daily [of Wobenzym® N or similar Mucos Pharma GmbH enzyme mixtures], we see improvement," Dr. Wrba says. "I have seen about one-third of cases of pancreatic cancer that were completely cured with about two-thirds not responding well, which for this cancer is an excellent outcome. Based on experience, the outcome for most patients is improved with systemic oral enzyme therapy. Enzymes rank as my favorite adjuvant medicine for every type of cancer. It is very essential to take them in very high doses. We can force a beneficial effect at 30 pills three times daily."

Today, in Europe, although enzymes are not necessarily officially part of cancer treatment protocols, Dr. Wrba estimates that about 90 percent of cancer patients are given them or told to take them unofficially. What happened many years ago to his Michaela Siedon could never be changed. But what Dr. Wrba has accomplished since then has changed the course of survival for so many cancer patients.

The Doctor's Prescription

Everyday Dr. Wrba takes 15 to 20 Wobenzym N tablets to help reduce his risk for cancer and to take advantage of their overall healthful properties. He advises anyone interested in reducing their cancer risk or in fighting premature aging to use Wobenzym N systemic oral enzymes, which are available at health food stores and natural product supermarkets nationwide.

In cancer treatment, work with your doctor, he advises. Dosages of up to 30 pills three times daily may be necessary.

How Systemic Oral Enzymes Modify Tumor Cells & Immune 

Function to Fight Cancer

References

Wrba, H. & Pecher, O. Enzymes: A Drug of the Future. Ecomed Verlagsgesellschaft AG & Co., 1993.

Systemic Oral Enzymes Page

www.freedompressonline.com/oralenzymes.htm 

Dr. Otto Warburg's lecture in 1966 states that if enzymes were put back into the food after processing it, that it would properly eliminate cancer almost totally from our nation.

WOBENZYM  LETTER - PAUL WINTERS

Hi Wayne,

There is the reason I list Wobenzym on my web site:

Combination therapy using B17 and vitamin A is based in part on the following study conducted by Harold Manner Ph.D., chairman of the biology department of Loyola University, Chicago. He used a combination of vitamin A (A-mulsin, produced by the Mugos Company) the same company's Wobe Mugos enzymes and B-17.

The results were reported in his book the Death of Cancer: After six to eight days an ulceration appeared at the tumor site. Within the ulceration was a pus like fluid. An examination of this fluid revealed dead malignant cells. The tumors gradually underwent complete regression in 75 of the experimental animals. This represented 89% of the total group. The remaining 9 animals showed partial regression.

When Manner repeated the experiment he tried different combinations of vitamins, enzymes, and B17. His results: B17 alone had no appreciable effect, but combinations of enzymes and or vitamin A with B17 was significantly more effective that just enzymes and/or vitamin A. Details and references from Total Health Associates, Columbus, OH

What Form of Enzymes?

Wobe Mugos enzymes are available in the USA as Wobenzym which contains Pancreatin and other enzymes not included in Wobe Mugos. Pancreatin has been recognized for many years as playing an important part in the B17 theory of cancer.

Wobe Mugos contains the follow per tablet:
      Papain......................100mg
      Trypsin........................40mg
      Chymotrypsin...............40mg

Wobenzym contains the follow per tablet:

      Pancreatin................100mg
      Papain........................60mg
      Bromelain....................45mg
      Trypsin........................24mg
      Chymotrypsin.................1mg
      Rutosid........................50mg

Take care, 

Paul

Click here for more information on the Wobenzym enzymes